Temperature Controlled Pharma Packaging Solutions Market
Market Insights on Temperature Controlled Pharma Packaging Solutions covering sales outlook, demand forecast & up-to-date key trends
Temperature Controlled Pharma Packaging Solutions Market By Product (Insulated Shippers, Insulated Protective Shippers, Insulated Containers), Application (Frozen, Chilled, Ambient) & Region - Forecast 2020 - 2030
Temperature Controlled Pharma Packaging Solutions Market Outlook (2022-2030)
[200 Pages Report] The global temperature controlled pharma packaging solutions market is projected to rise at 7.8% CAGR and reach a valuation of US$ 7.4 Bn by 2032, up from US$ 4 Bn in 2022.
|
Temperature Controlled Pharma Packaging Solutions Market Size (2022) |
US$ 4 Bn |
|
Sales Forecast (2030) |
US$ 7.4 Bn |
|
Global Market Growth Rate (2022 to 2030) |
7.8% CAGR |
|
Share of Top 5 Players |
55% |
Temperature controlled pharma packaging solutions currently account for 45% share of the global temperature controlled packaging market.
Let us know your requirement to get
100% FREE customization
Temperature Controlled Pharma Packaging Solutions Market Analysis (2015 To 2021) Vs Market Outlook (2022 To 2030)
“Growing Awareness about Product Safety to Boost Demand for Temperature Controlled Pharma Packaging Solutions”
From 2015 to 2021, the global temperature controlled pharma packaging solutions market registered significant gains, experiencing a CAGR worth 7.2%
Temperature controlled pharma packaging is commonly used for packing and shipping of various chemical goods that are temperature sensitive, as well as pharmaceutical medications to preserve temperature stability. These temperature controlled pharma packaging solutions are intended to extend the shelf life of a product in a moderate environment.
This packaging is primarily used to extend life of chemical products and pharmaceutical pharmaceuticals, as well as to maintain a variety of product-specific environmental factors, such as air quality levels. Any deviation from the recommended temperature for keeping and delivering pharmaceutical products may compromise the drug's efficacy.
As a result, they must be put in temperature controlled containers to avoid any damage to the product. By reducing the weight and volume of the resource for preserving the requisite thermal environment, temperature controlled pharma packaging solutions can deliver better solutions than typical and traditional insulating materials.
Considering these factors, the market is projected to witness high growth over the coming years, registering a CAGR of 7.8% to reach US$ 7.4 Bn by 2030.
What Is Driving Market Demand For Temperature Controlled Pharma Packaging Solutions?
“Next-gen Tracking Technology and High Insulation-based Packaging Solutions to Dictate Future Growth Prospects”
Temperature controlled pharma packaging solutions will continue to see a stronger influence of regulations, considering the nature of the products to be packed and shipped. Moreover, the demand for quality and compliance is growing at a faster rate than innovation. Market players are targeting reinforced composite materials with high insulation-based packaging solutions and stability to set their products apart from the competition.
The greater need for cost-effective solutions for highly temperature-sensitive shipments is likely to direct focus towards lightweight yet high insulation-based packaging solutions. Through next-gen shippers and data management devices, innovative technologies are making their way into the market space, enabling faster, more accurate transparency in the movement of sensitive pharma products.
What Challenges Are Hampering Market Growth?
“Stringent Regulations on Shipment of Temperature-Sensitive Products Restraining Market Growth”
High maintenance and investment cost pertaining to the temperature controlled pharmaceutical packaging solutions in the pharmaceutical industry is projected to hinder the market growth during the assessment period.
Lack of awareness concerning the benefits of packaging solutions since only a few companies utilize temperature controlled pharma packaging solutions may hinder the market growth. Furthermore, lots of precautions are required to uphold during pharmaceutical product packaging to ascertain their stability and protection such as the container should be dry and clean, etc.
Several stringent government legislations on the use of temperature-sensitive products for producing temperature controlled packaging solutions is estimated to restrict the market growth.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy Is Europe Expected To Lead The Temperature Controlled Pharma Packaging Solutions Market?
“Increasing Pharmaceutical Packaging Need in Healthcare Sector Fueling Market Growth in Europe”
The temperature controlled pharma packaging solutions market is dominated by Europe, which is predicted to develop significantly during the forecast period due to rising demand for cold storage medical items in the healthcare sector.
Europe has witnessed advancements in terms of pharmaceutical packaging that have been hesitated due to rising number of disease outbreaks.
Country-Wise Analysis
Where Does the U.S. Stand in the Global Market for Temperature Controlled Pharma Packaging Solutions?
“Rising Usage of Temperature Controlled Medical Products Driving Market Expansion”
The U.S. temperature controlled pharma packaging solutions market is expected to grow rapidly because of a huge number of pharmaceutical producers and increasing use of temperature controlled medical products.
As a result of the thriving pharmaceutical industry, demand for vaccines, pharmaceuticals, and other temperature controlled medical products is expected to rise, propelling the market in the U.S.
What is the Demand Outlook for Temperature Controlled Pharma Packaging Solutions in China?
“Continuous R&D Activities on Thermal Packaging Solutions to Augment Market Growth”
The market in China is expected to witness a faster growth rate because of the growing number of clinical trials. China has seen technological improvements as a result of its growing population and increasing number of disease outbreaks.
To stay ahead of the competition, several corporations have focused their R&D efforts on developing innovative thermal packaging solutions in China.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which Product Accounts for Highest Revenue Generation?
“Insulated Shippers Leading Market Growth Owing to Extreme Temperature Control Characteristics”
Insulated shippers are expected to remain lucrative in terms of market share and incremental revenue opportunities over the forecast period.
Insulated shippers are typical products of choice of distributors and suppliers to ship specialty pharmaceuticals and biologics, demand for PUR containers and fiberboard is expected to remain strong going forward.
Today, many pharmaceutical companies are turning to PUR insulated shippers as an alternative to their EPS counterparts, owing to high durability and sustainability, reduced risk of product failure, less space consumption, and more extreme temperature control. Additionally, insulated containers, both chest style and upright style are projected to garner significant traction in long-term dimensions.
Which Application Demands the Most Temperature Controlled Pharma Packaging Solutions?
“Growing Need for Better Product Handling to Boost Demand for Chilled Applications”
Chilled application is expected to account for 41.5% share of the temperature controlled pharma packaging solutions market in 2022. Pharmaceutical products, such as vaccines, blood samples, and medicinal medications, require a chilled application. It is critical to ensure that inventories are held at the correct narrow temperature range for them to be usable.
Pharmaceutical chilled stores keep products in a cold, regulated environment. This also helps to avoid the deterioration of temperature sensitive products that need to be stored safely in the medical and healthcare industries. Temperature-sensitive sensors will give you peace of mind since if there is any variation, backup units will be triggered promptly.
Additionally, dual control modulating cooling systems ensure that temperature variations are kept to a minimum at all times to protect. Putting money in specialized cold storage can be an excellent long-term alternative for a variety of pharmaceutical needs.
COVID-19 Impact on Market
The COVID-19 pandemic forced the closure of most manufacturing facilities, The COVID-19 pandemic has forced several businesses to re-establish their respective growth trajectory for approaching years. The market dropped in demand owing to the high influence of COVID-19. This is majorly due to disruption across supply chains.
For shipping vaccines, testing kits, and other important pharmaceuticals, companies invented their packing strategy. Temperature excursions can cause product damage in temperature controlled packaging. COVID-19 has pushed industry trends in temperature controlled pharmaceutical packaging solutions. Vaccine manufacturers cooperated with temperature controlled pharmaceutical packaging vendors to create specialized vaccine shipping products.
Competitive Landscape
Rapid technical innovations and advancements are crucial aspects of the expansion of the industry. Major companies are investing more in research & development to develop more efficient products to set their products apart from the competition.
For instance,
- Cryoport, Inc., a leading supplier of temperature controlled supply chain solutions for the life sciences sector, acquired CRYOPDP, a leading provider of advanced temperature controlled logistics solutions to pharmaceutical, clinical research, and gene & cell therapy markets. The acquisition will provide CRYOPDP noteworthy synergies with Cryoport's operating entity, Cryoport Systems, with very little overlap in infrastructure and capabilities, from a regional as well as product and service support viewpoint.
Temperature Controlled Pharma Packaging Solutions Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2030 |
|
Historical Data Available for |
2015-2021 |
|
Market Analysis |
Value in US$ Mn |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments Of Temperature Controlled Pharma Packaging Solutions Industry Survey
Temperature Controlled Pharma Packaging Solutions Market By Product :
- Insulated Shippers
- Panels and Envelopes
- EPS Foam Containers
- Fiberboards
- PUR Containers
- Insulated Protective Shippers
- Insulated Containers
- Chest Style
- Upright Style
- Others (Refrigerants, Gel, Icepacks, Phase Change Materials, etc.)
Temperature Controlled Pharma Packaging Solutions Market By Application :
- Frozen Temperature Controlled Pharma Packaging Solutions
- Chilled Temperature Controlled Pharma Packaging Solutions
- Ambient Temperature Controlled Pharma Packaging Solutions
Temperature Controlled Pharma Packaging Solutions Market By Region :
- North America Temperature Controlled Pharma Packaging Solutions Market
- Latin America Temperature Controlled Pharma Packaging Solutions Market
- Europe Temperature Controlled Pharma Packaging Solutions Market
- East Asia Temperature Controlled Pharma Packaging Solutions Market
- South Asia & Pacific Temperature Controlled Pharma Packaging Solutions Market
- Middle East & Africa (MEA) Temperature Controlled Pharma Packaging Solutions Market
Frequently Asked Questions
The global temperature controlled pharma packaging solutions market is worth US$ 4 Bn in 2022.
Sonoco Products Company, Pelican Biothermal, Sofrigam SA Ltd., Cryopak, and Cold Chain Technologies are major players in the market.
Chilled applications are estimated to hold 41.5% share in the global market.
Revenue from temperature controlled pharma packaging solutions is set to reach US$ 7.4 Bn by 2030.
Increasing prevalence of chronic diseases along with growing demand for temperature-sensitive products is expected to drive market growth.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation
4. Key Success Factors
4.1. Product Adoption
4.2. Product USP
4.3. Promotional Strategies
5. Global Temperature Controlled Pharma Packaging Solutions Market Demand Analysis 2015-2021 and Forecast, 2022-2030
5.1. Historical Market Volume (Units) Analysis, 2015-2021
5.2. Current and Future Market Volume (Units) Projections, 2022-2030
5.3. Y-o-Y Growth Trend Analysis
6. Global Temperature Controlled Pharma Packaging Solutions Market - Pricing Analysis
6.1. Regional Pricing Analysis
6.2. Pricing Break-up
6.3. Global Average Pricing Analysis Benchmark
7. Global Temperature Controlled Pharma Packaging Solutions Market Demand (Value in US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Global Economic Outlook
8.2. Global Packaging Market Outlook
8.3. Global Pharmaceutical Industry Outlook
8.4. Global Bio-pharma Industry Outlook
8.5. Global Flexible Packaging Market Outlook
8.6. Global Rigid Packaging Market Outlook
8.7. Macro-Economic Factors
8.7.1. Global GDP Growth Outlook
8.7.2. GDP Per Capita
8.7.3. Global Pharmaceutical Market
8.8. Forecast Factors - Relevance & Impact
8.8.1. Demand Growth of Temperature Sensitive Products
8.8.2. Segmental Revenue Growth of Key Players
8.8.3. Growth of Healthcare Industry
8.8.4. Global Packaging market Growth
8.9. Key Industry Perspectives: What Leaders Are Thinking?
8.10. Value Chain
8.10.1. Key Participants
8.10.1.1. Raw Material Suppliers
8.10.1.2. Temperature Controlled Pharma Packaging Solutions Manufacturers
8.10.1.3. Distributors
8.10.2. Profitability Margin
8.11. Market Dynamics
8.11.1. Drivers
8.11.2. Restraints
8.11.3. Opportunity Analysis
9. Global Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030, by Product
9.1. Introduction
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Product, 2015-2021
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Product, 2022-2030
9.3.1. Insulated Shippers
9.3.1.1. Panels and Envelopes
9.3.1.2. EPS Foam Container
9.3.1.3. Fiberboard
9.3.1.4. PUR Containers
9.3.2. Insulated Protective Shippers
9.3.3. Insulated Containers
9.3.3.1. Chest Style
9.3.3.2. Upright Style
9.3.4. Others
9.4. Market Attractiveness Analysis, by Product
10. Global Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030, By Application
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Application, 2015-2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, by Application, 2022-2030
10.3.1. Frozen
10.3.2. Chilled
10.3.3. Ambient
10.4. Market Attractiveness Analysis, by Application
11. Global Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis, by Region, 2015-2021
11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast, by Region, 2022-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Western Western Europe
11.3.4. Eastern Western Europe
11.3.5. APEJ
11.3.6. Middle East and Africa (MEA)
11.3.7. Japan
11.4. Market Attractiveness Analysis, by Region
12. North America Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Product
12.4.3. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By Application
12.6. Market Trends
13. Latin America Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product
13.4.3. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By Application
13.6. Market Trends
14. Western Western Europe Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. Italy
14.4.1.3. France
14.4.1.4. U.K.
14.4.1.5. Spain
14.4.1.6. Nordic
14.4.1.7. BENELUX
14.4.1.8. Rest of Western Western Europe
14.4.2. By Product
14.4.3. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Application
14.6. Market Trends
15. Eastern Western Europe Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
15.4.1. By Country
15.4.1.1. Russia
15.4.1.2. Poland
15.4.1.3. Rest of Eastern Western Europe
15.4.2. By Product
15.4.3. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Application
15.6. Market Trends
16. APEJ Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
16.4.1. By Country
16.4.1.1. China
16.4.1.2. India
16.4.1.3. ASEAN Countries
16.4.1.4. Australia & New Zealand
16.4.1.5. Rest of APEJ
16.4.2. By Product
16.4.3. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Application
16.6. Market Trends
17. Middle East and Africa Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
17.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. Northern Africa
17.4.1.3. South Africa
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product
17.4.3. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Application
17.6. Market Trends
18. Japan Temperature Controlled Pharma Packaging Solutions Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, by Market Taxonomy, 2015-2021
18.4. Market Size (US$ Mn) and Volume (Units) Forecast, by Market Taxonomy, 2022-2030
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By Application
18.6. Market Trends
19. Market Structure Analysis
19.1. Market Analysis, by Tier of Temperature Controlled Pharma Packaging Solutions Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product foot print by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive (Key Players)
20.3.1. Sonoco Products Company
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Profitability by Market Segments
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.2. Pelican Biothermal
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Sofrigam SA Ltd
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. Cryopak
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. Cold Chain Technologies
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. Envirotainer AB.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. va-Q-tec AG
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Inmark Packaging
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
20.3.9. American Aerogel Corporation
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Profitability by Market Segments
20.3.9.4. Sales Footprint
20.3.9.5. Strategy Overview
20.3.9.5.1. Marketing Strategy
20.3.9.5.2. Product Strategy
20.3.9.5.3. Channel Strategy
20.3.10. Snyder Industries, Inc
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Profitability by Market Segments
20.3.10.4. Sales Footprint
20.3.10.5. Strategy Overview
20.3.10.5.1. Marketing Strategy
20.3.10.5.2. Product Strategy
20.3.10.5.3. Channel Strategy
20.3.11. ACH Foam Technologies, LLC
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Profitability by Market Segments
20.3.11.4. Sales Footprint
20.3.11.5. Strategy Overview
20.3.11.5.1. Marketing Strategy
20.3.11.5.2. Product Strategy
20.3.11.5.3. Channel Strategy
20.3.12. Tempack Packaging Solutions, S.L.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Profitability by Market Segments
20.3.12.4. Sales Footprint
20.3.12.5. Strategy Overview
20.3.12.5.1. Marketing Strategy
20.3.12.5.2. Product Strategy
20.3.12.5.3. Channel Strategy
20.3.13. EcoCool GmbH
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Profitability by Market Segments
20.3.13.4. Sales Footprint
20.3.13.5. Strategy Overview
20.3.13.5.1. Marketing Strategy
20.3.13.5.2. Product Strategy
20.3.13.5.3. Channel Strategy
20.3.14. Exeltainer SL
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Profitability by Market Segments
20.3.14.4. Sales Footprint
20.3.14.5. Strategy Overview
20.3.14.5.1. Marketing Strategy
20.3.14.5.2. Product Strategy
20.3.14.5.3. Channel Strategy
20.3.15. Intelsius
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Profitability by Market Segments
20.3.15.4. Sales Footprint
20.3.15.5. Strategy Overview
20.3.15.5.1. Marketing Strategy
20.3.15.5.2. Product Strategy
20.3.15.5.3. Channel Strategy
20.3.16. Inno Cool India Private Limited
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Profitability by Market Segments
20.3.16.4. Sales Footprint
20.3.16.5. Strategy Overview
20.3.16.5.1. Marketing Strategy
20.3.16.5.2. Product Strategy
20.3.16.5.3. Channel Strategy
20.3.17. Softbox Systems
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Profitability by Market Segments
20.3.17.4. Sales Footprint
20.3.17.5. Strategy Overview
20.3.17.5.1. Marketing Strategy
20.3.17.5.2. Product Strategy
20.3.17.5.3. Channel Strategy
20.3.18. Insulated Products Corporation
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Profitability by Market Segments
20.3.18.4. Sales Footprint
20.3.18.5. Strategy Overview
20.3.18.5.1. Marketing Strategy
20.3.18.5.2. Product Strategy
20.3.18.5.3. Channel Strategy
20.3.19. TKT GmbH
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Profitability by Market Segments
20.3.19.4. Sales Footprint
20.3.19.5. Strategy Overview
20.3.19.5.1. Marketing Strategy
20.3.19.5.2. Product Strategy
20.3.19.5.3. Channel Strategy
20.3.20. Saeplast Americas Inc
20.3.20.1. Overview
20.3.20.2. Product Portfolio
20.3.20.3. Profitability by Market Segments
20.3.20.4. Sales Footprint
20.3.20.5. Strategy Overview
20.3.20.5.1. Marketing Strategy
20.3.20.5.2. Product Strategy
20.3.20.5.3. Channel Strategy
*The above list is indicative in nature and is subject to change during the course of research
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 02: Global Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume ('000 Units) Forecast, by Application, 2015-2030
Table 03: Global Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume ('000 Units) Forecast, by Region, 2015-2030
Table 04: North America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 05: North America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 06: North America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 07: Latin America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 08: Latin America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 09: Latin America Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 10: Western Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 11: Western Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 12: Western Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 13: Eastern Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 14: Eastern Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 15: Eastern Europe Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 16: APEJ Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 17: APEJ Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 18: APEJ Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 19: MEA Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 20: MEA Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Table 21: MEA Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Country, 2015-2030
Table 22: Japan Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Product Type, 2015-2030
Table 23: Japan Temperature Controlled Packaging Solutions for Pharmaceuticals Market Value (US$ Mn) and Volume (‘000 Units) Forecast, by Application, 2015-2030
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 02: Global Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 03: Global Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 04: Global Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 05: Global Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Region 2021(A) - 2030(F)
Figure 06: Global Temperature Controlled Pharma Packaging Solutions Share Analysis by Region, 2022(E) & 2030(F)
Figure 07: North America Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 08: North America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 09: North America Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 10: North America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 11: North America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 12: North America Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 13: Latin America Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 14: Latin America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 15: Latin America Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 16: Latin America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 17: Latin America Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 18: Latin America Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 19: Western Europe Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 20: Western Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 21: Western Europe Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 22: Western Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 23: Western Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 24: Western Europe Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 25: Eastern Europe Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 26: Eastern Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 27: Eastern Europe Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 28: Eastern Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 29: Eastern Europe Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 30: Eastern Europe Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 31: APEJ Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 32: APEJ Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 33: APEJ Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 34: APEJ Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 35: APEJ Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 36: APEJ Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 37: MEA Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 38: MEA Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 39: MEA Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 40: MEA Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 41: MEA Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Figure 42: MEA Temperature Controlled Pharma Packaging Solutions Share Analysis by Country, 2022(E) & 2030(F)
Figure 43: Japan Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Product 2022(E) & 2030(F)
Figure 44: Japan Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Product 2021(A) - 2030(F)
Figure 45: Japan Temperature Controlled Pharma Packaging Solutions Market Share Analysis, by Application 2022(E) & 2030(F)
Figure 46: Japan Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Application 2021(A) - 2030(F)
Figure 47: Japan Temperature Controlled Pharma Packaging Solutions Attractiveness Analysis, by Country 2021(A) - 2030(F)
Need specific information?
Request CustomizationExplore Packaging Insights
View Reports
